“Why might Northwest Bio want commercial manufacturing ready by a certain time period, and incentivize Advent (through milestone payments) to do so? Why did Mike Scott’s team (Advent) make “an extraordinary effort to meet a 2nd quarter deadline” to submit the MIA application? “ — hyperopia